Evaluation of exercise capacity with cardiopulmonary exercise testing and type B natriuretic peptide concentrations in adult patients with patent atrial septal defect

Cardiology

Volumn 106, Issue 3, 2006, Pages 154-160

  Trojnarska, Olga ^a   Szyszka, Andrzej ^a   Gwizdala, Adrian ^a   Oko Sarnowska, Zofia ^a   Katarzynski, Slawomir ^a   Siniawski, Andrzej ^a   Chmara, Ewa ^a   Cieslinski, Andrzej ^a  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

Author keywords

Adult patients with atrial septal defect; Brain natriuretic peptide; Cardiopulmonary exercise testing

Indexed keywords

BIOCHEMICAL MARKER; BRAIN NATRIURETIC PEPTIDE;

ADULT; ARTICLE; CARDIOPULMONARY EXERCISE TEST; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATIONAL STUDY; ECHOCARDIOGRAPHY; EXERCISE TEST; FEMALE; HEART ATRIUM SEPTUM DEFECT; HEART RIGHT VENTRICLE VOLUME; HUMAN; LUNG BLOOD FLOW; LUNG FLOW VOLUME CURVE; MALE; OXYGEN CONSUMPTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SYSTEMIC CIRCULATION;

ADULT; ECHOCARDIOGRAPHY; EXERCISE TEST; FEMALE; HEART FUNCTION TESTS; HEART SEPTAL DEFECTS, ATRIAL; HUMANS; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; RESPIRATORY FUNCTION TESTS; SPIROMETRY;

EID: 33749185434     PISSN: 00086312     EISSN: None     Source Type: Journal    
DOI: 10.1159/000092770     Document Type: Article

References (40)

1. Attie F, Rosas M, Granados N, Zabal C, Buendia A, Calderon J: Surgical treatment for secundum atrial septal defects in patients aged over 40 years old. J Am Coll Cardiol 2001;38:2035-2042.
2. Ghosh S, Chatterjee S, Black E, Firmin RK: Surgical closure of atrial septal defects in adults: effect of age at operation on outcome. Heart 2002;88:485-487.
3. Jemielity M, Dyszkiewicz W, Paluszkiewicz L, Perek B, Buczkowski P, Poniżynski A: Do patients over 40 years of age benefit from surgical closure of atrial septal defects? Heart 2001;85:300-303.
4. Gatzoulis MA, Redington AN, Somerville J, Shore D: Should atrial septal defects in adults be closed? Am Thorac Surg 1996;61:657-659.
5. Webb G, Horlick E: Lessons from cardiopulmonary tasting after device closure of secundum atrial septal defect. J Am Coll Cardiol 2004;43:1892-1893.
6. Vogel M, Berger F, Kramer A, Alexi-Meshkshvili V, Lange PE: Incidence of secondary pulmonary hypertension in adults with atrial septal or sinus venosus defects. Heart 1999;82:30-33.
7. Giardini A, Donti A, Formigari R, Specchia S, Prandstraller D, Bronzetti G, Bonvicini M, Picchio FM: Determinants of cardiopulmonary functional improvement after transcatheter atrial septal defect in asymptomatic patients. J Am Coll Cardiol 2004;43:1886-1891.
8. Giardini A, Donti A, Specchia S, Coutsoumbas G, Formigari R, Prandstraller D, Bronzetti G, Bronvicini M, Picchio FM: Recovery kinetics of oxygen uptake is prolonged in adults with an atrial septal defect and improves after transcatheter closure. Am Heart J 2004;147:910-914.
9. Helber U, Baumann R, Seboldt H, Reinhard U, Hoffmeister HM: Atrial septal defect in adults: cardiopulmonary exercise capacity before and 4 months and 10 years after defect closure. J Am Coll Cardiol 1997;29:1345-1350.
10. Oelberg DA, Marcotte F, Kreisman H, Wolkove N, Langleben DM, Small D: Evaluation of right ventricular systolic pressure during incremental exercise by Doppler echocardiography in adults with atrial septal defect. Chest 1998;113:1459-1465.
11. Reybrouck T, Bisschop A, Domoulin M, van der Hauwaert LG: Cardiorespiratory exercise capacity after surgical closure of atrial septal defect is influenced by the age at surgery. Am Heart J 1991;122:1073-1078.
12. Veldtman GR, Razack V, Siu S: Right ventricular form and function after percutaneous atrial septal defect device closure. J Am Coll Cardiol 2001;37:2108-2113.
13. Brochu MC, Baril JF, Dore A, Juneau M, De Guise P, Mercier LA: Improvement in exercise capacity in asymptomatic and mildly symptomatic adults after atrial septal detect percutaneous closure. Circulation 2002;106:1821-1826.
14. 2. Eur Heart J 2000;21:154-161.
15. Buller NP, Poole-Wilson PA: Mechanism of increased ventilatory response to exercise in patients with chronic heart failure. Br Heart J 1990;63:281-283.
16. Gackowski A, Isnard R, Piwowarska W, Komajda M: B-type natriuretic peptide. New tool in clinical cardiology. Kardiol Pol 2002;56:644-648.
17. Guidelines for the diagnosis and treatment of chronic heart failure. European Society of Cardiology. Eur Heart J 2001;22:1527-1560.
18. Bolger AP, Sharma R, Li W, Leenarts M, Kalra PR, Kemp M, Coats AJS, Anker SD, Gatzoulis MA: Neurohormonal activation and the chronic heart failure syndrome in adults with congenital heart disease. Circulation 2002;106:92-99.
19. Mair J, Hammerer-Lercher A, Puschendorf B: The impact of cardiac natriuretic peptide determination on the diagnosis and management of heart failure. Clin Chem Lab Med 2001;39:571-588.
20. Cleland JCF, Goode K: Natriuretic peptides for heart failure. Fashionable? Useful? Necessary? Eur J Heart Fail 2004;6:253-255.
21. Sanderson JE: BNP or echocardiography for monitoring heart failure? Eur Heart J 2004;25:1763-1764.
22. Berger R, Huelsman M, Strecker K, Bojick A, Moser P, Stanek B, Pacher R: B-natriuretic peptide predicts sudden death in patients with chronic heart failure Circulation 2002;105:2392-2397.
23. Tulewski II, Groenink M, van der Wall EE, van Valdhuisen DJ, Boomsma F, Stoker J, Hirsch A, Lemkes JS, Mulder BJM: Increased brain and atrial natriuretic peptides in patients with chronic right ventricular pressure overload: correlation between plasma neurohormones and right ventricular dysfunction. Heart 2001;86:27-30.
24. Hopkins WE, Chen Z, Fukagava NK, Hall C, Knot HJ, LeWinter MM: Increased atrial and brain natriuretic peptides in adults with cyanotic congenital heart disease. Enhanced understanding of the relationship between hypoxia and natriuretic peptide secretion. Circulation 2004;109:2872-2877.
25. Nagaya N, Nishikimi T, Okano Y, Uematsu M, Satoh T, Kyotani S, Kuribayashi S, Hamada S, Kakishita M, Nakanishi N, Takamaya M, Kunieda T, Matsuo H, Kangawa K: Plasma brain natriuretic peptide levels increase in proportion to the extend of right ventricular dysfunction in pulmonary hypertension. J Am Coll Cardiol 1998;31:202-208.
26. Livainen TE, Groundstroem KWE, Lahtela JT, Telvansaari TJ, Pasternack A, Uusitalo A: Plasma N-terminal atrial natriuretic peptide in adult patients late after surgical repair of atrial septal defect. Eur Heart J 2000;2:161-165.
27. Kikuchi K, Hishioka K, Ueda T, Shiomi M, Takahashi Y, Sugawara A, Nakao K, Imura H, Mori C, Mikawa H: Relationship between plasma atrial natriuretic polypeptide concentration and haemodynamic measurement in children with congenital heart diseases. J Pediatr 1987;111:335-342.
28. Ohuchi H, Takasugi H, Ohashi H, Yamada O, Watanabe K, Yagihara T, Echigo S: Abnormalities of neurohormonal and cardiac autonomic nervous activities relate poorly to functional status in Fontan patients. Circulation 2004;110:2601-2608.
29. Fredriksen PM, Veldtman G, Hechter S, Therrien J, Chen A, Warsi MA, Freeman M, Liu P, Siu S, Thaulow E, Webb G: Aerobic capacity in adults with various congenital heart disease. Am J Cardiol 2001;87:310-314.
30. Reybrouck T, Martens L, Brusselle S, Weymans M, Eyskens B, Defoor J, Gewillig M: Oxygen uptake versus exercise intensity: a new concept in assessing cardiovascular exercise function in patients with congenital heart disease. Heart 2000;84:46-52.
31. Rhodes J, Patel H, Hijazi Z: Effect of transcatheter closure of atrial septal defect on the cardiopulmonary response to exercise. Am J Cardiol 2002;90:803-806.
32. Graham TP: Ventricular performance in congenital heart disease. Circulation 1991;84:2259-2274.
33. Davies H, Gazetopoulus N: Haemodymanic changes on exercise in patients with left-to-right shunts. Br Heart J 1966;27:579-589.
34. De Troyer A, Yernault JC, Englert M: Mechanism of breathing in patients with atrial septal defect. Am Rev Respir Dis 1977;115:413-421.
35. Sulc J, Andrle V, Hruda J, Hucin B, Samanek M, Zapletal A: Pulmonary function in children with atrial septal defect before and after surgery. Heart 1998;80:484-488.
36. Hogg JC, Agarawal JB, Gardiner AJ, Palmer WH, Macklem PT: Distribution of airway resistance with developing pulmonary oedema in dogs. J Appl Physiol 1972;32:20-24.
37. Hirata N, Shimazaki Y, Sakakibara T: Response of right ventricular systolic function to exercise stress: effects of pulmonary vascular resistance on right ventricular systolic function. Ann Nucl Med 1994;8:125-131.
38. Otto CM: The Practice of Clinical Echocardiography, ed 2. Philadelphia, W .B. Saunders Company, 2002, p 747.
39. Kruger S, Graf J, Kunz D, Stickel T, Hanrath P, Janssens U: Brain natriuretic peptide levels predict functional capacity in patients with chronic heart failure. J Am Coll Cardiol 2002;40:718-722.
40. Hill NS, Klinger JR, Warburton RR, Pietras L, Wrenn DS: Brain natriuretic peptide: possible role in the modulation of hypoxic pulmonary hypertension. Am J Physiol 1994;266:308-318.